P2X7 nucleotide receptor activation enhances IFN gamma-induced type II nitric oxide synthase activity in BV-2 microglial cells.
about
P2X7 receptor activation induces reactive oxygen species formation and cell death in murine EOC13 microgliaPurinergic signalling in neuron-glia interactionsThe role of the P2X7 receptor in murine cutaneous leishmaniasis: aspects of inflammation and parasite controlNeurobiology of microglial action in CNS injuries: receptor-mediated signaling mechanisms and functional rolesMicroglial phenotype and adaptation.Luminal flow regulates NO and O2(-) along the nephronThe developing oligodendrocyte: key cellular target in brain injury in the premature infantEstrogen and P2 Purinergic Receptor Systems in Microglia: Therapeutic Targets for Neuroprotection.Transcriptional control mechanisms associated with the nucleotide receptor P2X7, a critical regulator of immunologic, osteogenic, and neurologic functions.Activation of ERK1/2 by extracellular nucleotides in macrophages is mediated by multiple P2 receptors independently of P2X7-associated pore or channel formation.Chronic ethanol exposure combined with high fat diet up-regulates P2X7 receptors that parallels neuroinflammation and neuronal loss in C57BL/6J mice.Inflammatory Pathways in Parkinson's Disease; A BNE Microarray Study.Co-Expression of Wild-Type P2X7R with Gln460Arg Variant Alters Receptor FunctionATP mediates flow-induced NO production in thick ascending limbs.Nucleotide receptor signalling and the generation of reactive oxygen species.P2x7 deficiency suppresses development of experimental autoimmune encephalomyelitis.Pathogenesis of cerebral white matter injury of prematurity.The cytokine IL-1beta transiently enhances P2X7 receptor expression and function in human astrocytes.New insights into purinergic receptor signaling in neuronal differentiation, neuroprotection, and brain disorders.Therapeutic potential of extracellular ATP and P2 receptors in nervous system diseases.P2Y6 receptor and immunoinflammationP2X7 antagonism using Brilliant Blue G reduces body weight loss and prolongs survival in female SOD1G93A amyotrophic lateral sclerosis mice.Inhibiting purinergic P2X7 receptors with the antagonist brilliant blue G is neuroprotective in an intranigral lipopolysaccharide animal model of Parkinson's disease.ATP is required and advances cytokine-induced gap junction formation in microglia in vitro.P2X7 receptor-pannexin 1 hemichannel association: effect of extracellular calcium on membrane permeabilization.Lysophosphatidylcholine potentiates Ca2+ influx, pore formation and p44/42 MAP kinase phosphorylation mediated by P2X7 receptor activation in mouse microglial cells.Purinergic modulation of microglial cell activation.Onset of microglial entry into developing quail retina coincides with increased expression of active caspase-3 and is mediated by extracellular ATP and UDP.Mechanical loading affects the energy metabolism of intervertebral disc cells.Extracellular ATP activates eNOS and increases intracellular NO generation in Red Blood Cells.P2X7 Receptor Signaling Contributes to Sepsis-Associated Brain Dysfunction.P2Y1 and cysteinyl leukotriene receptors mediate purine and cysteinyl leukotriene co-release in primary cultures of rat microglia.P2X7 receptor activation in rat brain cultured astrocytes increases the biosynthetic release of cysteinyl leukotrienes.Effects of propofol on P2X7 receptors and the secretion of tumor necrosis factor-α in cultured astrocytes.P2X4 receptor channels form large noncytolytic pores in resting and activated microglia.Development of an AmpliSeq Panel for Next-Generation Sequencing of a Set of Genetic Predictors of Persisting Pain
P2860
Q21285096-E368F2C7-1AA6-4939-B7B0-DB8D7D80E7FFQ24684324-DAD1BD7A-129F-4ABA-AF5F-03FD1999F4BDQ33689420-4CCA140A-95A1-4515-AFE5-888153067A0BQ34002086-F8199209-9B8E-411B-846F-351FE7F8B046Q34359569-1EEE1E50-5403-4FBA-9EAC-120B56417695Q34979632-CA356616-1296-4BA8-AF3F-66D70ED16985Q34995998-35CB967C-8A42-466B-B565-3A7C7F726FC3Q35234329-0F7E8DE9-0D3E-4C77-B9EB-A351CD5FD0B6Q35468810-FEFC2BF0-9CC7-4D77-A74C-908FDBBD48BEQ35545223-2BF8BA91-F3C9-4BEA-ABB5-099E71953BE2Q35882017-912A1C32-0417-4121-B8CC-C49592301629Q35884924-392BD937-9C49-4728-9330-A7E94479F951Q35961235-1CD4C3B4-0102-49D0-94CE-BDA9BE10FB13Q36114996-0A6309E7-947B-4F3C-9BFF-CD66C9B52915Q36174261-121BCD28-071F-4D9A-9F32-39DE6DE1A869Q36842750-7F766B2D-572F-47C4-8624-019EF220E359Q36941006-4D310F40-FBE1-44C7-A220-B99138629AA1Q36981077-68E2E997-D0B4-44B2-98D1-6371E4B560FDQ37135526-B19C4875-6301-4B4A-97CE-5334BDBDFD0CQ37384723-D1B2E02E-606A-48D6-A577-EE07125D87E2Q37485961-C484BB91-9DBA-4DC1-AB9D-E1DF2723B090Q37679001-E324F0A5-1062-4AA0-AF04-2F2931D23ACEQ37720013-D77A59E8-E33B-4D07-86E9-69639C55B7BCQ39143832-EA45058B-B677-4688-999F-87846A5CE48FQ39471255-E79B1938-03EB-4C46-A8BA-E03AC0FE72F8Q40145211-92F28331-5AD9-4012-A11E-ED7A5C5CD4B9Q40729696-F1C17B7F-1FB2-48EB-9E81-6D77B9ED5C70Q41200305-6D4B950C-DDA0-4458-A894-11AD3D667968Q41966483-3C86CC81-5810-4C76-957E-3B9DFFB6CC7FQ42516919-3BABD05A-2BEA-467A-A212-254E0A179FBFQ46479061-634895D1-3DBE-4A3F-8FD7-D2B28A95E4CBQ46485747-F63159F1-2462-4C11-B2F6-42B29D1C8DC0Q46705016-74390D1E-D3F6-4CB6-98B6-C2315C53D49FQ48261318-D598649D-8909-4972-9250-877607AF233DQ53186766-2B8C815F-737E-4CD7-83D6-776B1EB7FB17Q57072929-1BD0226F-6567-4A6B-AC8C-CFA43F16CBA8
P2860
P2X7 nucleotide receptor activation enhances IFN gamma-induced type II nitric oxide synthase activity in BV-2 microglial cells.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
P2X7 nucleotide receptor activ ...... vity in BV-2 microglial cells.
@en
type
label
P2X7 nucleotide receptor activ ...... vity in BV-2 microglial cells.
@en
prefLabel
P2X7 nucleotide receptor activ ...... vity in BV-2 microglial cells.
@en
P2093
P2860
P1476
P2X7 nucleotide receptor activ ...... vity in BV-2 microglial cells.
@en
P2093
Fernand-Pierre Gendron
Fernando A González
Gary A Weisman
Grace Y Sun
Joanna Strosznajder
Malgorzata Chalimoniuk
Siming Shen
P2860
P304
P356
10.1046/J.1471-4159.2003.01995.X
P407
P577
2003-10-01T00:00:00Z